Wikisage, the free encyclopedia of the second generation, is digital heritage
Clobazam: Difference between revisions
Jump to navigation
Jump to search
(→Links) |
m (→Links: q) |
||
| Line 9: | Line 9: | ||
==Links== | ==Links== | ||
[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3994921/pdf/10.1177_1756285614521314.pdf Experience in the use of clobazam in the treatment of Lennox–Gastaut syndrome] | [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3994921/pdf/10.1177_1756285614521314.pdf Experience in the use of clobazam in the treatment of Lennox–Gastaut syndrome] | ||
{{Wikidata| | |||
{{Wikidata|Q412164}} | |||
==ATC== | ==ATC== | ||
Revision as of 02:01, 26 May 2017
-
-
Median reduction in total seizure frequency with antiepileptic drugs approved for Lennox–Gastaut syndrome
Clobazam is a broad espectrum AED [1] Hypothermia episodes has been described[2]
Links
Experience in the use of clobazam in the treatment of Lennox–Gastaut syndrome
